NEW CORRECTION METHODS OF THE INTESTINAL DYSBACTEIOSIS IN CHILDREN WITH CHRONIC HEPATITIS B WITH REGARD TO BODY SENSITIVITY

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/8774

Full metadata record

DC Field	Value	Language
dc.contributor.author	Nurmatova N.F.	-
dc.date.accessioned	2023-06-24T11:19:25Z	-
dc.date.available	2023-06-24T11:19:25Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/8774	-
dc.description.abstract	Aim: To evaluate efficacy of biopreparations by lymphocyte sensitivity in vitro in children with chronic hepatitis B (CHB). Methods: 47 children with CHB were studied at the age 3-14 years with intestinal dysbacteriosis (ID): II (21.3%); III (38.3%); IV (40.4%). Test in vitro used to body sensitivity to Lacto-G, Narimax-plus and Bifilax-immuno (UZ IAP 04570, 2022). Biocorrection of ID was performed on basic therapy with use of highly sensitive for body biopreparation. Group of comparison of 20 patients with CHB receiving Bifidum- and Lactobacterin.	en_US
dc.language.iso	en_US	en_US
dc.publisher	O'zbekiston, Toshkent	en_US
dc.title	NEW CORRECTION METHODS OF THE INTESTINAL DYSBACTEIOSIS IN CHILDREN WITH CHRONIC HEPATITIS B WITH REGARD TO BODY SENSITIVITY	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
70.pdf	NEW CORRECTION METHODS OF THE INTESTINAL DYSBACTEIOSIS IN CHILDREN WITH CHRONIC HEPATITIS B WITH REGARD TO BODY SENSITIVITY	814.52 kB	Adobe PDF	View/Open

DSpace JSPUI